A carregar...
Crizotinib resistance: implications for therapeutic strategies
In 2007, a chromosomal rearrangement resulting in a gene fusion leading to expression of a constitutively active anaplastic lymphoma kinase (ALK) fusion protein was identified as an oncogenic driver in non-small-cell lung cancer (NSCLC). ALK rearrangements are detected in 3%–7% of patients with NSCL...
Na minha lista:
| Publicado no: | Ann Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003168/ https://ncbi.nlm.nih.gov/pubmed/27573756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw305 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|